A recent human [18F]PI-2620 (Figure 7f) PET study of AD showed no off-target binding in the basal ganglia (i.e., MAO-B binding) in contrast to [18F]THK-5351 (Figure 3g) and other first-generation tau tracers [123]. Here, MAPT is linked to Alzheimer disease.